Bon Secours Mercy Health is in late-stage talks to buy a majority stake in Surgery Partners, the Financial Times reported, citing people familiar with the matter. The talks value the group at about 20 dollars a share, or about 6 billion dollars on Bloomberg’s headline figure. The report describes a majority stake rather than a full acquisition, and the talks are not a signed deal.
Bon Secours nears six billion dollar Surgery Partners takeover
Bon Secours Mercy Health is in late-stage talks to buy a majority stake in Surgery Partners at about 20 dollars a share, valuing the surgical centres group at about 6 billion dollars, the Financial Times reported.
Why it matters: A majority sale would hand a large United States outpatient surgery network to a not-for-profit hospital system and end Surgery Partners' run as a listed, Bain Capital backed company, if the talks produce a signed deal.
Data as of Financial Times reporting of October 25, 2026, as carried by Bloomberg the same day and read in this run; Bloomberg's page showed one sentence of text before its paywall, and that sentence is the source for the parties, the majority stake, the late-stage status and the 20 dollars a share figure, with the 6 billion dollar valuation from Bloomberg's headline. The FT cited people familiar with the matter, and no company confirmation was visible in the reporting read. Developing item.
Sources
- Bon Secours Nears $6 Billion Takeover of Surgery Partners, FT Reports - Bloomberg - 2026-10-25